These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24578473)

  • 1. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay.
    Welsh P; Smith K; Nelson SM
    Hum Reprod; 2014 May; 29(5):1035-41. PubMed ID: 24578473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.
    Li HW; Wong BP; Ip WK; Yeung WS; Ho PC; Ng EH
    Hum Reprod; 2016 Dec; 31(12):2796-2802. PubMed ID: 27702835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
    Han X; McShane M; Sahertian R; White C; Ledger W
    Hum Reprod; 2014 May; 29(5):1042-8. PubMed ID: 24626805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two new automated, compared with two enzyme-linked immunosorbent, antimüllerian hormone assays.
    Nelson SM; Pastuszek E; Kloss G; Malinowska I; Liss J; Lukaszuk A; Plociennik L; Lukaszuk K
    Fertil Steril; 2015 Oct; 104(4):1016-1021.e6. PubMed ID: 26183313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.
    Rustamov O; Smith A; Roberts SA; Yates AP; Fitzgerald C; Krishnan M; Nardo LG; Pemberton PW
    Hum Reprod; 2012 Oct; 27(10):3085-91. PubMed ID: 22777530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.
    Iliodromiti S; Salje B; Dewailly D; Fairburn C; Fanchin R; Fleming R; Li HWR; Lukaszuk K; Ng EHY; Pigny P; Tadros T; van Helden J; Weiskirchen R; Nelson SM
    Hum Reprod; 2017 Aug; 32(8):1710-1715. PubMed ID: 28854583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay.
    van Helden J; Weiskirchen R
    Hum Reprod; 2015 Aug; 30(8):1918-26. PubMed ID: 26093541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II).
    Wallace AM; Faye SA; Fleming R; Nelson SM
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):370-3. PubMed ID: 21628625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative comparison of anti-Müllerian hormone measurement and its shifting boundaries between two assays.
    de Kat AC; Broekmans FJM; van Westing AC; Lentjes E; Verschuren WMM; van der Schouw YT
    Maturitas; 2017 Jul; 101():12-16. PubMed ID: 28539163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First fully automated immunoassay for anti-Müllerian hormone.
    Gassner D; Jung R
    Clin Chem Lab Med; 2014 Aug; 52(8):1143-52. PubMed ID: 24622790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparability of antimüllerian hormone levels among commercially available immunoassays.
    Su HI; Sammel MD; Homer MV; Bui K; Haunschild C; Stanczyk FZ
    Fertil Steril; 2014 Jun; 101(6):1766-72.e1. PubMed ID: 24726216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the Ultrasensitive Anti-Müllerian Hormone Assay for Predicting True Ovarian Reserve.
    Iwase A; Osuka S; Nakamura T; Kato N; Takikawa S; Goto M; Kikkawa F
    Reprod Sci; 2016 Jun; 23(6):756-60. PubMed ID: 26614267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone measurement.
    Craciunas L; Roberts SA; Yates AP; Smith A; Fitzgerald C; Pemberton PW
    Fertil Steril; 2015 Feb; 103(2):554-59.e1. PubMed ID: 25487749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
    van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
    Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a second generation anti-Müllerian hormone (AMH) ELISA.
    Kumar A; Kalra B; Patel A; McDavid L; Roudebush WE
    J Immunol Methods; 2010 Oct; 362(1-2):51-9. PubMed ID: 20801125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.